AcelRx Pharmaceuticals Inc. (ACRX)

2.93 +0.09 (+3.169%)

IEX Real-Time Price

November 16, 2018 EST.

NASDAQ Global Market : Healthcare

Prev Close 2.84

Price Open 2.88

Volume: 2.3M

Avg Volume: 6.35M

Market Cap: 181.39M

P/E Ratio -3.49

52 Wk Range 1.65-5.05



ACRX Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-10-15
59.22M
8.7M
1.78
14.70%

2018-09-28
59.25M
3.9M
4.27
6.58%

2018-09-14
59.25M
3.17M
6.94
5.35%

2018-08-31
59.25M
3.25M
6.01
5.49%




ACRX Earning Report


Report Date
Fiscal Period
Announce Time
Estimated EPS(#)
Actual EPS
Surprise Dollar

2018-11-02
Q3 2018
N/A
-0.20 (4)
-0.21
-0.01

2018-08-02
Q2 2018
AMC
-0.19 (3)
-0.20
-0.01

2018-05-14
Q1 2018
N/A
-0.23 (2)
0.00
0.00

2018-05-09
Q1 2018
AMC
-0.24 (2)
-0.23
0.01

News

AcelRx Pharmaceuticals to Present at the 17th Annual ASRA Pain Medicine Meeting (2018-11-14 16:05 PR Newswire)

REDWOOD CITY, Calif. , Nov. 14, 2018 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the use in medically supervised settings, today announced an upcoming presentat…

 

AcelRx Will Go It Alone With Dsuvia, But The Future Looks Bright (2018-11-14 11:19 SeekingAlpha)

After receiving FDA approval for its lead drug candidate Dsuvia last Friday, November 2, AcelRx (NASDAQ: ACRX ) held a conference call at 8:30AM EST on Monday , November 5, to discuss the company's plans going forward as a commercial-stage company. Though some observers, myself included,…

 


Statistics

Shares Outstanding: 61.91M

Top 15 Institution Percent: 15.20

Price To Sales: 77.18

Price To Book: 42.26

Revenue: N/A

Gross Profit: N/A

Cash: N/A

Debt: N/A

Return On Assets: -55.43

Return On Equity: 130.63

Profit Margin: N/A

Price History

Beta: 1.85

50-day Moving Avg: 3.70

200-day Moving Avg: 2.96

YTD Change: 42.93

5-day Change: -9.85

1-month Change: -29.90

3-month Change: -3.93

6-month Change: -2.33

1-year Change: 41.20

Revenue Per Share: 0.00

Revenue Per Employee: 0.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: AcelRx Pharmaceuticals Inc.

Exchange: NASDAQ Global Market

Industry: Medical Devices

Sector: Healthcare

Website: http://www.acelrx.com

AcelRx Pharmaceuticals Inc is a specialty pharmaceutical company. It is engaged in the development and commercialization of therapies for the treatment of acute pain.